FDA inspection
Glaxo Operations UK Ltd.: FDA inspection ending May 16, 2017
FDA inspection 1061592 · Voluntary Action Indicated (VAI) · Stevenage
Key facts
| Inspection ID | 1061592 |
|---|---|
| Firm | Glaxo Operations UK Ltd. |
| FEI number | 3009763376 |
| Address | Medicines Research Centre |
| City | Stevenage |
| Country | United Kingdom |
| Fiscal year | 2017 |
| Inspection end date | May 16, 2017 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data